“Deep Dive″ or uncut version of our video podcast. Drs Jeff Brown and Jeff Cole interview Dr. David Kay (CMO) and Gabe Szabo (CEO) or Surgical Targeted Solutions, Inc. Both gentlemen have had enormous success building and operating medical companies. For Dr. Kay, Orthohelix was the first company that he helped form, build and exit.

As technology continues to rapidly advance in healthcare, there are times when solutions don’t bring adequate value when compared to the steep learning curves and restrained budgets. As just one example, rather than trying to find ways to use robotic assistance in surgery for an increasing number of things, some of the most impactful potential gains relate to improving process and understanding “why we do what we do”.

One example of this is in the surgical treatment of hip fractures. Given the changing population demographics, hip fractures are expected to rise dramatically over the next 10 years, all while the surgeon pool is shrinking. As new surgeons come on board to deal with this exploding volume, there risks a wide range in skill and experience level that make OR staffing very difficult. It’s hard to allocate resources when the same operation can range from 30 minutes to 120 minutes.

Has the team at Surgical Targeted Solutions, Inc. found a potential solution for this problem and created a cost-effective, simple tool that provides reliability and reproducibility for improved hip fracture outcomes?

The first step in the surgical treatment is placement of a guidewire within a center-head position. This solution changes an unguided first step to one that is computer-assisted and guided so that optimal positioning of the implant can be achieved THE FIRST TIME…EVERY TIME.

Compared with robot-assisted procedures, this solution offers affordability, simplicity, adaptability and an easy or quick learning curve. This system can also be used in the training of residents to bring balance between skill and experience levels.

The benefits to cost and outcome are significant and include decreased OR time, more predictable procedure length, fewer complications, less radiation and reduction in implant waste or explants.

During the FDA process and early commercialization, Surgical Targeted Solution, Inc will be highly focused on the hip fracture market. With that said there are numerous additional adaptations covered under their patent and where solutions and business will be developed.

*****

Would this bring value to you, your family or your medical practice? Investable merits of this company? Let’s discuss in the forum.

If you are a physician or healthcare professional with an NPI number, you can register for our private forum to join the discussion. Sign up today!

https://mergemedical.community.forum/

*****

DISCLAIMER: Merge Medical and the podcast hosts are providing this content for informational and entertainment purposes only and are not broker dealers or registered investment advisors. We are not providing investment or legal advice. We will bring awareness to interesting projects and companies and then leave further discussion of the clinical and/or investable merits of these companies up to free discussion within the forum. Additionally, podcast participants (including the hosts) and Merge Medical forum members may or may not have a financial interest within the companies being interviewed or featured.

Stated as a matter of fact, cybersecurity is a big f*^&%ing deal.

Join us in a Deep Dive version of the Merge Medical podcast as Dr. Jeff Brown and Dr. Jeff Cole interview Dr. Jose Bolanos. Dr. Bolanos is founder and CEO of Nimbus-T Global and offers a compelling opportunity for enterprise and individuals alike to protect themselves in a world full of bad actors.

Cybersecurity threats can hit home in so many ways. Unfortunately, the medical profession and healthcare industry seem to be like fish in a barrel. Constant threats, frequent losses...and few, if any, wins.

In addition to high profile ransomware attacks such as Change Healthcare and Ascension, there are countless direct attacks on medical practices. One of these attacks can easily bankrupt a successful, long standing medical practice.

With billion-dollar market cap companies trying to create meaningful solutions and put a notch in the win column, is it possible that a physician holds the keys to one of the most revolutionary solutions in existence?

Moving well beyond two-factor authentication (2FA) and multi-factorial authentication (MFA), Nimbus-T Global / Nimbus-Key ID provides the most advanced cybersecurity protection at login to enterprise systems. The Nimbus-Key ID mobile app registers each user with KYC/AI/Biometric verification. The user logs into the mobile app with True User Verification and the system bypasses passwords with dynamically encrypted ID in a QRcode (DE-MFA). This system protects the enterprise login process and the user’s true access.

Also, having experience with poor cooperation across the myriad of software systems required for the day-to-day activities of both office-based and hospital-based physicians, much thought has gone into the time efficiency of the hardware-agnostic process.

If you have escaped direct cybersecurity threat or loss up to this point, some experts would say that it’s only a matter of time.

Tune in to the latest Merge Medical podcast to learn more.

*****

Would this bring value to you, your family or your medical practice? Investable merits of this company? Let’s discuss in the forum.

If you are a physician or healthcare professional with an NPI number, you can register for our private forum to join the discussion. Sign up today!

https://mergemedical.community.forum/

*****

DISCLAIMER: Merge Medical and the podcast hosts are providing this content for informational and entertainment purposes only and are not broker dealers or registered investment advisors. We are not providing investment or legal advice. We will bring awareness to interesting projects and companies and then leave further discussion of the clinical and/or investable merits of these companies up to free discussion within the forum. Additionally, podcast participants (including the hosts) and Merge Medical forum members may or may not have a financial interest within the companies being interviewed or featured.

Welcome to the Merge Medical Podcast, where today’s healthcare innovators and leaders come together to shape tomorrow’s healthcare landscape. In our latest episode, we’re honored to host Dr. Robert Pearl, the former CEO of Kaiser Permanente, a prolific author and a visionary in the fields of AI and healthcare.

Dr. Robert Pearl was the CEO of The Permanente Medical Group (Kaiser Permanente) from 1999-2017. In this role he led 12,000 physicians, 42,000 staff and was responsible for the nationally recognized medical care of over 5 million Kaiser Permanente members on the west and east coasts.

His newest book, “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine” debuted as #1 on Amazon’s “New Best Seller” list. All profits from the book go to Doctors Without Borders. He is also the author of “Mistreated: Why We think We’re Getting Good Healthcare—And Why We’re Usually Wrong,” a Washington Post bestseller and “Uncaring: How the Culture of Medicine Kills Doctors and Patients,” published May 2021.

Pearl, named one of Modern Healthcare’s 50 most influential physician leaders, serves as a clinical professor of plastic surgery at Stanford University School of Medicine and is on the faculty of the Stanford Graduate School of Business.

He hosts the popular podcasts Fixing Healthcare and Medicine: The Truth, publishes a newsletter called Monthly Musings on American Healthcare, and is a regular contributor to Forbes.

Dr. Pearl received his medical degree from the Yale University School of Medicine and completed his residency at Stanford University.

Connect with Dr. Robert Pearl on Twitter @RobertPearlMD, LinkedIn and at his website robertpearlmd.com.